Searl T J, Silinsky E M
Department of Molecular Pharmacology, Northwestern University Medical School, Chicago, Illinois 60611, USA.
J Pharmacol Exp Ther. 1998 Apr;285(1):247-51.
Recent work from our laboratory has demonstrated that phorbol esters known to stimulate protein kinase C (PKC) also stimulate acetylcholine (ACh) secretion by an action at a strategic component of the secretory apparatus [ J Physiol (Lond) 501:41-48]. In an attempt to determine whether the stimulatory effects of phorbols are mediated by PKC, we examined the effects of several PKC antagonists on ACh release promoted by phorbol 12,13-dibutyrate (PDBu) at the frog neuromuscular junction. PKC antagonists that act at the ATP binding site (C3 domain) were examined for their ability to antagonize the stimulatory action of PDBu. Neither the nonselective PKC inhibitor, staurosporine (at concentrations as high as 1 microM), nor its more selective derivative, GF109203X (at concentrations as high as 10 microM), attenuated the stimulatory effects of PDBu. PKC antagonists that act at the phorbol ester binding site (C1 domain) were examined for their ability to antagonize the stimulatory action of PDBu. Neither sphingosine (500 microM) nor calphostin C (25 microM) reduced the stimulatory actions of PDBu on ACh release. These results suggest that a presynaptic protein possessing a phorbol ester receptor and not the enzyme PKC is the target site for the stimulatory effects of phorbol esters at motor nerve endings.
我们实验室最近的研究表明,已知能刺激蛋白激酶C(PKC)的佛波酯,也能通过作用于分泌装置的一个关键成分来刺激乙酰胆碱(ACh)的分泌[《生理学杂志》(伦敦)501:41 - 48]。为了确定佛波酯的刺激作用是否由PKC介导,我们研究了几种PKC拮抗剂对佛波醇12,13 - 二丁酸酯(PDBu)在青蛙神经肌肉接头处促进ACh释放的影响。研究了作用于ATP结合位点(C3结构域)的PKC拮抗剂拮抗PDBu刺激作用的能力。非选择性PKC抑制剂星形孢菌素(浓度高达1微摩尔)及其更具选择性的衍生物GF109203X(浓度高达10微摩尔)均未减弱PDBu的刺激作用。研究了作用于佛波酯结合位点(C1结构域)的PKC拮抗剂拮抗PDBu刺激作用的能力。鞘氨醇(500微摩尔)和钙泊三醇C(25微摩尔)均未降低PDBu对ACh释放的刺激作用。这些结果表明,在运动神经末梢,具有佛波酯受体的突触前蛋白而非PKC酶是佛波酯刺激作用的靶点。